Craft

IRIDEX

Stock Price

$1.6

2024-10-29

Market Capitalization

$26.8 M

2024-10-29

Revenue

$52.7 M

FY, 2026

IRIDEX Summary

Company Summary

Overview
IRIDEX is an ophthalmic medical technology company focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. It offers lasers, retinal surgical instruments, veterinary products, retina delivery devices, glaucoma devices, etc.
Type
Public
Status
Active
Founded
1989
HQ
Mountain View, CA, US | view all locations
Website
https://www.iridex.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • David I. Bruce, President and CEO, Director

    • Fuad Ahmad

      Fuad Ahmad, Chief Financial Officer

    • Patrick Mercer, Chief Operating Officer

    • Scott Shuda

    Operating MetricsView all

    Product Lines

    5

    FY, 2022

    Manufacturing Facilities, sq. ft.

    37

    FY, 2022

    Patents (US)

    62
    8.8%

    FY, 2022

    LocationsView all

    2 locations detected

    • Mountain View, CA HQ

      United States

      1212 Terra Bella Ave

    • Mannheim, BW

      Germany

      Carl-Reuther-Straße 3

    IRIDEX Financials

    Summary Financials

    Revenue (FY, 2026)
    $52.7M
    Gross profit (FY, 2026)
    $19.2M
    Net income (FY, 2026)
    ($4.4M)
    Cash (FY, 2026)
    $6.0M
    EBIT (FY, 2026)
    ($2.6M)
    Enterprise value
    $25.3M

    Footer menu